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Clear cell renal cell carcinoma (ccRCC) is the most common and malignant tumor in the adult 
kidney, representing 75-80% of renal primary malignancies. Inactivation of the von Hippel-Lindau 
(VHL) tumor suppressor gene, by mutation, deletion and promoter methylation, occurs in most 
sporadic ccRCCs and in all inherited cases. Recent evidences showed that microRNAs (miRNAs) 
are often dysregulated in many tumors, including ccRCC. 
We used Caki-1, Caki-2 and A498 cell lines as in vitro model of ccRCC pathology, and HK-2 
(normal proximal tubular epithelial cell line) as reference sample. We characterized the VHL status 
by direct sequencing and the HIF status by western blot. Affymetrix microarray technology was 
applied to assess miRNA (onto GeneChip® miRNA Array) and gene expression profiles (onto 
GeneChip® Human Gene 1.0 ST Array). 
Analysis of common differentially expressed miRNAs (DEMs) in RCC cell lines outlined specific 
miRNAs to be involved in ccRCC and in cancer (e.g. miR-145, miR-29a, miR-342-3p, miR-205, 
miR-183, miR-197, miR-132, miR-146a and miR-34a). Functional enrichment analysis of common 
differentially expressed genes (DEGs) highlighted some genes involved in leucocyte 
transendothelial migration, focal adhesion and p53 signalling pathways (e.g. ATM, FER, CDC27 
and GRB10). Additionally, we conducted an integrated analysis to combine gene and miRNA 
expression profiles and to reconstruct miRNA-gene post-transcriptional regulatory networks 
involved in RCC pathology. We also compared our expression data with RCC datasets publicly 
available from NCBI GEO microarray repository. We selected potentially interesting miRNAs and 
target genes for further validation (by qPCR). This integrated analysis approach may help to 
unravel the molecular complexity characterizing ccRCC biology, and it will facilitate the elucidation 
of regulatory circuits important for tumorigenesis and the biological processes under relevant post-
transcriptional regulation in ccRCC. 
